NCT06429150
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
Clinical trial condition
Plasmacytoma
Explore clinical trials studying Plasmacytoma. Study availability and eligibility vary by location and protocol.
8 public trials
1 recruiting study
Plasmacytoma trial results
NCT02506959
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome
NCT02921893
- Conditions
- Abnormalities, Multiple, Blood Protein Disorders, Congenital Abnormalities, +16 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02184533
- Conditions
- Adenocarcinoma of the Prostate, Blood Protein Disorders, Cardiovascular Diseases, +26 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
NCT02547662
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Sarah Cannon Cancer Center Nashville, Tennessee, United States
NCT00421525
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Center for Cancer Care Goshen, Indiana, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
NCT04174196
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
Active, Not Recruiting
Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
NCT02544308
- Conditions
- Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, +4 more
- Locations
-
- Royal United Hospital Bath, United Kingdom
- Blackpool Victoria Hospital Blackpool, United Kingdom
- University Hospital Wales Cardiff, United Kingdom
- Velindre Cancer Centre Cardiff, United Kingdom